The metabolic state of a cell is influenced by cellextrinsic factors, including nutrient availability and growth factor signaling. Here, we present extracellular matrix (ECM) remodeling as another fundamental node of cell-extrinsic metabolic regulation. Unbiased analysis of glycolytic drivers identified the hyaluronan-mediated motility receptor as being among the most highly correlated with glycolysis in cancer. Confirming a mechanistic link between the ECM component hyaluronan and metabolism, treatment of cells and xenografts with hyaluronidase triggers a robust increase in glycolysis. This is largely achieved through rapid receptor tyrosine kinasemediated induction of the mRNA decay factor ZFP36, which targets TXNIP transcripts for degradation. Because TXNIP promotes internalization of the glucose transporter GLUT1, its acute decline enriches GLUT1 at the plasma membrane. Functionally, induction of glycolysis by hyaluronidase is required for concomitant acceleration of cell migration. This interconnection between ECM remodeling and metabolism is exhibited in dynamic tissue states, including tumorigenesis and embryogenesis.
INTRODUCTION
Cells have diverse circuitry to sense and respond to extrinsic metabolic signals. For example, cells coordinate systemic and cellular metabolism by sensing nutrient availability through mTORC1 and shifting between catabolic and anabolic states accordingly (Saxton and Sabatini, 2017) ; growth factors, hormones, and cytokines can relay metabolic cues to adjacent cells and to distal tissues as part of a broader biological response. The unifying effect integrates the behavior and metabolism of the cell with the requirements of the tissue and organism.
Another cell-extrinsic signal is extracellular matrix (ECM) reorganization, which is central to both tissue expansion and regeneration, with embryogenesis and wound healing being hallmark cases, respectively (Adams and Watt, 1993; Raghow, 1994; Toole, 2001) . ECM remodeling is also a signature of pathological processes, such as tumorigenesis (Bissell and Radisky, 2001; Hanahan and Weinberg, 2011) . Many of these processes rely upon increased glycolytic metabolism, which can provision the energetic currency and biosynthetic substrates required for rapid proliferation (DeBerardinis et al., 2008; Purcell and Moley, 2009) . Although ECM remodeling and elevated glycolysis are coincident in multiple biological contexts, the mechanistic links between these processes are not well established.
Given the importance of anchorage-independent growth to tumorigenesis, categorical changes in matrix attachment and their metabolic implications have been described. ECM detachment of mammary epithelial cells causes a reduction in glucose uptake and subsequent ATP deficiency, both restorable with oncogene expression (Grassian et al., 2011; Schafer et al., 2009) . Further supporting the idea that disengagement from the ECM can dramatically alter cell metabolism-specifically by repressing glycolysis-circulating tumor cells show induction of oxidative metabolism compared with their counterparts in both primary tumors and secondary metastatic sites (LeBleu et al., 2014) . Collectively, these reports describe the metabolic implications of binary changes in cell attachment to the ECM (i.e., attached versus detached). What remains unclear is whether specific perturbations in ECM composition can serve 
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(A) Genes were ranked on the vertical axis by average correlation of expression with the glycolytic index in 31 breast cancer cell lines and with FDG maximum standardized uptake value (SUV max ) in 11 patient breast tumors. Tumor transcript levels are presented in order of increasing SUV max on the horizontal axis. Adapted from Hong et al. (2016) . (B) Linear regressions correlating HMMR expression with FDG uptake in patient breast tumors (n = 11) and the glycolytic index in breast cancer cell lines (n = 31). The HMMR probe that generated the highest average correlation between tumors and cell lines is shown.
(legend continued on next page)
as dynamic signals to modulate the metabolism of cells in the context of a tissue.
Hyaluronan (HA, or hyaluronic acid), a ubiquitous ECM constituent, is a megadalton glycosaminoglycan that ensheaths the cell in a voluminous pericellular matrix through tethering interactions with its plasma membrane (PM) receptor, CD44, and the HA-mediated motility receptor (HMMR), although interactions with other receptors have been described (Toole, 2001 (Toole, , 2004 Turley et al., 2002) . The exact signaling events orchestrated by HA are dependent on its abundance and its size; oligomers of HA have been reported to exert distinct effects on cell behavior (Jiang et al., 2007; Stern et al., 2006) . As a result, the biological effects of HA are spatially patterned by the net activity of HA synthases (the enzymes that synthesize the polymer) and hyaluronidases (the enzymes that cleave it) in proximity of the cell.
Despite the simple structure of the HA polymer-disaccharide repeats of glucuronic acid and N-acetylglucosamineits effects on both normal biology and pathology are diverse. Beyond regulation of cell behavior through its receptors, HA may have a role in establishing the permissiveness of the environment for cells to proliferate, migrate, and-in cancermetastasize. Both HA and hyaluronidase, however, have been implicated in tumor progression, suggesting either a nonlinear role in the disease or a high degree of subtype specificity (Itano et al., 2002; Toole, 2004; Zhang et al., 1995) . The importance of HA in development, however, is clear: deletion of the HA synthase gene HAS2 is embryonically lethal, given impairment of endothelial cell migration required for cardiac development (Camenisch et al., 2000) . In this study, we show that increased migration in response to HA perturbation in cultured cells is dependent on a concomitant increase in glucose metabolism. We furthermore show that increased glucose metabolism in response to HA digestion also occurs in vivo and elucidate the signaling mechanisms involved. We therefore propose that ECM remodeling serves as an additional node of acute cell-extrinsic metabolic regulation, one that can directly read out the structural state of the surrounding tissue and augment cell behavior accordingly.
RESULTS

Unbiased Analysis Identifies ECM Engagement as a Regulator of Glycolytic Metabolism
We previously described an unbiased analysis to identify genes whose expression correlates with a glycolytic phenotype in breast cancer cell lines and tumors . Gene expression was correlated with the cellular glycolytic index in 31 breast cancer cell lines and with uptake of the glucose analog positron emission tomography (PET) tracer 18 F-fluorodeoxyglucose (FDG) in 11 patient breast tumors. Genes were rankordered based on their average correlation between cell lines and tumors, and SLC16A1 (encoding monocarboxylate transporter 1, MCT1) had the highest average correlation ( Figure 1A ). In studies that validate the effectiveness of this unbiased approach and its potential generalizability beyond breast cancer, we have described the roles MCT1 plays in cancer cell metabolism and proliferation, and in stem cell pluripotency . The second most correlated gene is the HA receptor HMMR ( Figures 1A and 1B) . This was surprising because the ECM has not been widely described as a direct regulator of glycolytic metabolism, nor is it often considered in the context of standard cell culture. However, many adherent cell types assemble a pericellular matrix comprised largely of HA polymers anchored to the PM (Cohen et al., 2003) . This can be visualized using biotinylated HA binding protein (HABP) ( Figure 1C ). When cells are treated with bovine testicular hyaluronidase (HAase), the pericellular matrix is digested away, but this does not occur with heatinactivated HAase (HI HAase).
Consistent with a role for HA in regulating glucose metabolism, LiSa-2 liposarcoma cells treated with HAase for 24 hr show a dose-dependent induction of glycolysis, as measured by glucose uptake and lactate production ( Figures 1D and S1A ). HI HAase does not affect glycolysis, suggesting that the effect is mediated by HAase enzymatic activity rather than thermostable contaminants ( Figure 1D ). Because LiSa-2 cells have a low baseline rate of glucose uptake, we used them-along with additional cell lines-as a model to examine glycolytic activation by HAase.
To confirm that HAase on-target effects are responsible for the induction of glycolysis, LiSa-2 cells were co-treated with HAase and the HAase inhibitor apigenin (Kuppusamy et al., 1990) . Apigenin abolishes the effect of HAase on glucose uptake and lactate production ( Figure S1B ). To further validate that HA modulation culminates in elevated glycolysis, we examined whether chemical inhibition of HA synthesis affects glucose uptake by treating LiSa-2 cells with 4-methylumbelliferone (4-MU) ( Figures  1E and S1C ). Disruption of HA pericellular matrix assembly phenocopies HA digestion, with 4-MU increasing glucose consumption ( Figure 1F ). These data suggest that the absence of full-length HA on the cell surface-by HAase digestion or inhibition of HA synthesis-can trigger an increase in glycolysis.
(C) HABP staining (yellow) of LiSa-2 cells after 4 hr treatment with PBS, 400 mg/mL HAase, or 400 mg/mL heat-inactivated (HI) HAase (concentrations used throughout the study unless otherwise stated). Nuclei were stained with DAPI (blue). Scale bar, 25 mm. (D) Glucose uptake and lactate production rates in LiSa-2 cells treated with PBS, HAase, or HI HAase for 24 hr. (E) HABP staining of LiSa-2 cells treated with 4-MU or DMSO 24 hr prior to fixation. Cells were also treated with PBS or HAase 4 hr prior to fixation. Scale bar, 50 mm. (F) Glucose uptake rates in LiSa-2 cells measured between 24 hr and 48 hr after treatment with 4-MU or DMSO. (G) Representative PET and CT images of a severe combined immunodeficiency (SCID) mouse bearing A549 xenografts on each flank, at baseline and 6 hr after intratumoral injection of HAase or HI HAase (indicated by red hatched circles). K and B indicate kidneys and bladder, respectively. (H) Relative tumor FDG signal in each A549 xenografted mouse (n = 5 mice) before and after 6 hr of treatment with HAase and HI HAase. The ratio of mean intensity between the tumor ultimately treated with HAase and that with HI HAase was calculated at baseline and after treatment on a per-mouse basis. The ratios for each mouse are displayed. The mouse shown in (G) is highlighted in red. All experiments were biological replicates. Error bars denote SD (n = 3, unless otherwise indicated). *p < 0.05, **p < 0.01, ***p < 0.001.
To determine whether the glycolytic response to matrix digestion with HAase occurs in vivo, we examined the effects of HAase in a xenograft model. We imaged A549 xenografts using FDG-PET/computed tomography (CT) at baseline and 6 hr after intratumoral injection with HAase and HI HAase (one preparation per flank so that each mouse received active and dead enzymes) ( Figure 1G ). The mean FDG uptake in each HAase-treated tumor was normalized to the paired HI HAase-treated tumor to account for variability among the animals. Tumor FDG uptake increased following HAase treatment, with four of five mice responding ( Figure 1H ). These data collectively indicate that matrix digestion with HAase can promote increased glucose metabolism in both cultured cells and tumors.
Matrix Digestion with HAase Acutely Increases Glycolytic Metabolism in a Broad Range of Cultured Cells
In an attempt to stratify cells that have a glycolytic response to HAase from those that do not, we measured glucose uptake ( Figure 2A ) and lactate production ( Figure 2B ) in a panel of cell lines, which included primary and immortalized cells, murine and human cells, as well as cancer cells representing a diversity of genetic lesions. All treated cells showed increased glycolytic metabolism. Changes in glutamine uptake ( Figure S1D ), by contrast, were both bidirectional and of a generally smaller magnitude. The differences in glucose and glutamine consumption underscore the specificity of the glycolytic response to HAase.
To assess the timing of the glycolytic response to HAase, we treated cells for 24 hr and 5 days. LiSa-2 cells and mouse embryonic fibroblasts (MEFs) showed a sustained response to HAase ( Figure 2C ). These sustained changes in glycolysis were visually evident in the acidification of the cell culture media, a proxy for lactate production ( Figure 2D ). 293T cells, however, do not show a similarly sustained response to HAase, with glucose uptake reverting toward the baseline rate after 5 days ( Figure 2E ). This suggests that there may be an acute, universal response to HAase and a specific, sustained response in certain cell types.
Canonical HA Receptors Are Likely Not Involved in the Glycolytic Response to HAase
We then attempted to determine whether HA interaction with its canonical receptors mediates the glycolytic response to its enzymatic cleavage. HMMR and CD44 are the best characterized, and the latter has been described as a mediator of glycolysis (Slomiany et al., 2009; Tamada et al., 2012) . There are, however, divergent changes in levels of these receptors after 24 hr of HAase treatment (Figures S2A and S2D) .
Consistent with our unbiased analysis suggesting a positive correlation between HMMR and glycolysis, HMMR knockdown in LiSa-2 cells caused baseline glucose uptake to fall below the sensitivity of our measurements ( Figures S2A and S2B ) despite no effect on cell viability ( Figure S2C ). HAase treatment, however, lowered HMMR levels ( Figure S2A ). Although the correlation between HMMR expression and glycolysis served as a compelling entré e into the study of HA and its effect on metabolism, these results are inconsistent with a direct effect of HMMR levels on the glycolytic response to HAase. CD44 was upregulated in response to HAase, but knockdown of the receptor did not abolish the glycolytic response to HAase (Figures S2D and S2E) . Although one of the CD44-targeted short hairpin RNAs (shRNAs) blunted the increase in glucose uptake after HAase treatment, the levels of CD44 were not proportional to glucose uptake. Furthermore, although most cell lines tested showed CD44 upregulation after HAase treatment, one showed no change in levels, and another did not express CD44 ( Figure S2F ). Although these data suggest that CD44 does not mediate the glycolytic response to HAase, it should be noted that MDA-MB-453 cells, without detectable levels of CD44, showed a relatively low-magnitude induction of glycolysis (Figures 2A and 2B) . It is therefore possible that part of the glycolytic response to HAase is due to binary signaling through CD44, irrespective of the levels of the receptor.
HAase Enriches GLUT1 at the PM To identify the node by which HAase upregulates glycolysis, we examined the transcript and protein levels of glycolytic enzymes after HAase treatment and found neither upregulation of the Kyoto Encyclopedia of Genes and Genomes (KEGG)-defined glycolytic gene set ( Figure S2G ) nor changes in glycolytic enzyme levels ( Figure S2H ). We then assessed functional changes, measuring the activity of hexokinase (HK), phosphofructokinase (PFK), and lactate dehydrogenase (LDH) (Figure S2I ). The only change was a decrease in HK activity with treatment. This suggests that there is spare glycolytic capacity at several steps in the pathway and that glucose entry into glycolysis may be rate-limiting.
Analysis of metabolite pool sizes by liquid chromatographymass spectrometry (LC-MS) can identify altered nodes in the glycolytic pathway (Hu et al., 2016) . If a treatment were to activate a rate-limiting glycolytic enzyme, you would expect to observe a selective increase in downstream metabolites and/ or a decrease in its substrate. However, we found that HAase treatment increased the levels of all measured glycolytic intermediates in LiSa-2 cells at 6 hr and 24 hr, consistent with a bottleneck at the level of glucose availability ( Figure 3A) . Underscoring the specificity of the glycolytic response, the downstream effects of HAase on the tricarboxylic acid (TCA) cycle were limited: U-13 C 6 -glucose tracer analysis showed increased glucose incorporation only into malate ( Figure S2J ), coupled with bidirectional changes in intermediate pool sizes (Figure S2K ).
To identify whether HAase affects glucose entry into the cell, we examined the subcellular distribution of the canonical glucose transporters GLUT1-GLUT4 following HAase treatment. GLUT1 staining in LiSa-2 cells was concentrated in punctae surrounding the nucleus in control cells, whereas it was more diffuse after HAase treatment ( Figure 3B ). To confirm that GLUT1 is enriched at the PM, we fractionated cells and saw increased GLUT1 (and GLUT3) in the PM fraction after HAase treatment ( Figure 3C ). The stable MCT1 PM levels indicate that HAase has a specific effect on glucose transporters rather than promoting global upregulation or redistribution of PM proteins.
We then examined whether changes in the PM levels of glucose transporters correspond with changes in glycolysis. We observed that both the extracellular acidification rate All experiments were biological replicates. Error bars denote SD (n = 3, unless otherwise indicated). *p < 0.05,**p < 0.01, ***p < 0.001.
(ECAR, a real-time proxy for lactate production) and PM GLUT1 and GLUT3 levels were increased by 6 hr of treatment with HAase ( Figures 3D and 3E ). To further characterize these kinetics, we measured the incorporation of U-13 C 6 -glucose carbons into glycolytic intermediates over a time course in HAasetreated MEFs ( Figure S2L ). Early pathway intermediates (e.g., fructose 1,6/2,6-bisphosphate [FBP] ) were nearly fully labeled at 5 min, but dihydroxyacetone phosphate (DHAP) and lactate showed escalating incorporation of the tracer over time that was accelerated by HAase. This corresponds with increased pool sizes of glycolytic intermediates after 6 hr and 24 hr of treatment ( Figure S2M ). These metabolomics data indicate that HAase promotes increased glycolysis starting at 6 hr, which aligns with the timing of the response in both ECAR and GLUT1 PM localization in LiSa-2 cells ( Figures 3D and 3E) .
To determine how HAase regulates GLUT1 and GLUT3, we examined their transcript levels after HAase treatment (Figure 3F) . Although SLC2A3 (GLUT3) is upregulated at both time points, SLC2A1 (GLUT1) is decreased at 4 hr and upregulated at 24 hr. Given the inconsistent result with SLC2A1, we then measured total protein levels at multiple time points of HAase treatment and in multiple cell lines; the GLUT1 levels remained unchanged ( Figure 3G ). These data suggest that, although the increases in PM GLUT3 may be due to transcriptional induction, the enrichment of GLUT1 is largely due to changes in subcellular distribution.
To assess whether increases in PM GLUT1 and GLUT3 are universal responses to HAase, we fractionated 293T and MDA-686 cells after HAase treatment ( Figure 3H ). Both cell lines showed increased PM GLUT1 in response to HAase but did not show similar consistency in GLUT3. We therefore concluded that GLUT1 is likely the common mediator of the glycolytic response to HAase, although changes in transcription or trafficking of other glucose transporters might augment the effect of HAase in some cells.
TXNIP Reduction Can Mediate the Acute Glycolytic Response to HAase
We then sought to determine how HAase affects GLUT1 localization. There are well established mediators of GLUT1 distribution between intracellular compartments and the cell surface, including TXNIP, whose transcript levels were anti-correlated with the glycolytic phenotype in our initial unbiased analysis (Figure 1A) . TXNIP regulates both the transcription and trafficking of GLUT1, the latter by binding PM GLUT1 and promoting its internalization in clathrin-coated pits (Patwari et al., 2009; Wu et al., 2013) . TXNIP levels dropped acutely after HAase treatment in multiple cell lines ( Figure 4A ). All cell lines tested showed reduced TXNIP levels after 2 hr of HAase treatment, which may explain the increased PM GLUT1 levels after 6 hr. To confirm that the TXNIP reduction represents an on-target effect of HAase, we tested two additional enzyme sources: hyaluronidase isolated from Streptomyces hyaluronlyticus and recombinant human PH-20. Both hyaluronidases reduced TXNIP levels with a magnitude similar to bovine testicular HAase ( Figure S3A ).
We next used Txnip knockout (KO) MEFs to test whether the glycolytic response to HAase could be attributed to negative regulation of Glut1 by Txnip. As previously described, Txnip KO cells have higher baseline rates of glucose uptake and lactate production than their wild-type (WT) counterparts ( Figure 4B ) and higher baseline PM Glut1 levels ( Figure 4C ; Elgort et al., 2010) . After confirming that HAase reduces Txnip levels in WT MEFs ( Figure 4D ), we fractionated both WT and KO MEFs after HAase treatment ( Figure 4E ). Although WT MEFs showed a robust induction of PM Glut1, KO cells showed only a modest response ( Figure 4E, heatmap) . Consistent with the hypothesis that altered Glut1 trafficking is largely responsible for mediating the glycolytic response to HAase, Txnip KO MEFs showed a lower-magnitude increase in glucose uptake and lactate production in response to HAase ( Figure 4F ).
ZFP36 Is Rapidly Induced by HAase and Targets TXNIP Transcripts for Degradation
We next asked which upstream events might culminate in the acute TXNIP reduction following HAase treatment. TXNIP is regulated at both the transcriptional and post-translational level; the acute change in TXNIP protein suggests the latter possibility. AMPK, a well characterized regulator of glucose metabolism and cellular energy homeostasis, can phosphorylate TXNIP and accelerate its proteasomal degradation (Wu et al., 2013 ), which we confirmed in LiSa-2 cells using an AMPK activator, A-769662. However, AMPK was not activated in response to HAase treatment ( Figure S3B ). We then investigated whether JNK pathway activation results in TXNIP depletion. The E3 ubiquitin ligase ITCH targets TXNIP and is activated by JNK phosphorylation and by HAase ( Figure S3C ; Wu et al., 2013; Zhang et al., 2010) . Pretreating LiSa-2 cells with a JNK inhibitor, SP600125, prevented ITCH activation upon HAase treatment but only had a modest rescue effect on TXNIP levels ( Figure S3C ) and did not result in a decreased induction of glucose uptake ( Figure S3D ) or GLUT1 PM enrichment ( Figure S3E ).
To more broadly examine whether HAase treatment results in TXNIP protein degradation, we overexpressed the coding sequence of TXNIP in LiSa-2 cells and then treated the cells with HAase. We saw a robust decrease in endogenous TXNIP but not in the ectopically expressed TXNIP ( Figure 5A ). This suggested that the HAase-mediated drop in TXNIP levels is not likely to be due to proteasomal degradation but, instead, likely due to transcriptional repression or mRNA processing of TXNIP. Indeed, TXNIP transcript levels dropped by over 50% after 1 hr of HAase treatment in 293T, MDA-686, and LiSa-2 cells ( Figure 5B ).
Because there is an AU-rich element (ARE) in the TXNIP 3 0 UTR, we explored the involvement of mRNA processing. We constructed a reporter with a luciferase gene fused to the TXNIP 3 0 UTR and measured luminescence in HAase-treated HEK293 cells. Luciferase activity was reduced in treated cells ( Figure 5C ), indicating that HAase either activates mRNA processing factors or targets them toward the TXNIP 3 0 UTR, both of which would culminate in degradation of the reporter. These results are consistent with matrix digestion by HAase acutely stimulating TXNIP mRNA degradation.
We identified an mRNA processing factor whose expression is rapidly induced by HAase in all cell lines tested: zinc-finger protein 36 (ZFP36, also known as tristetraprolin) ( Figure 5D ). Originally cloned and identified as a gene inducible by insulin and 12-O-tetradecanoylphorbol-13-acetate (TPA), ZFP36 can be rapidly and transiently induced by a variety of mitogens (Blackshear, 2002; Lim et al., 1989) and engages with the AREs of its short-lived target transcripts to promote their destabilization through recruitment of a deadenylase complex (Sandler et al., 2011) . Demonstrating that ZFP36 is at least among the processing factors that target the TXNIP 3 0 UTR, we saw a dose-dependent decrease in luciferase activity when a ZFP36 expression vector was co-transfected with the TXNIP 3 0 UTR reporter, with dose defined as the amount of ZFP36 expression vector DNA transfected ( Figure 5E ). . PM Glut1 band intensities were quantified and normalized to Na,K-ATPase; heatmaps represent Z scores from the resulting ratios.
(F) Glucose uptake and lactate production rates in WT and Txnip KO MEFs treated with PBS or HAase. The rates for each cell line were normalized to the PBS control. All experiments were biological replicates. Error bars denote SD (n = 3). *p < 0.05, **p < 0.01, ***p < 0.001.
To determine whether ZFP36 promotes degradation of TXNIP mRNA in response to matrix digestion with HAase, we compared the timing of changes in ZFP36 and TXNIP protein levels (Figure 5F ). There was synchronized divergence of the two proteins, with ZFP36 induction preceding the drop in TXNIP in 293T, LiSa-2, and MDA-686 cells. To directly interrogate involvement of ZFP36, we knocked it down in LiSa-2 cells and then treated them with HAase ( Figure 5G ). Both shRNAs reduced ZFP36 induction upon HAase treatment, and the shRNA with the stronger knockdown (shZFP36-2) also showed stronger rescue of TXNIP levels. Importantly, ZFP36 knockdown in LiSa-2 cells also blocked the increase in glucose uptake upon HAase treatment ( Figure 5H ). This suggests that ZFP36-mediated degradation of TXNIP mRNA plays a critical role in the glycolytic response to HAase in LiSa-2 cells.
To examine whether ZFP36-mediated TXNIP depletion is a common response to HAase treatment, we knocked down ZFP36 in an additional cell line, MDA-686. Strong ZFP36 knockdown with shZFP36-1 rescued the HAase-mediated drop in TXNIP levels ( Figure S4A ). However, shZFP36-2 caused a weaker knockdown of ZFP36 and showed no rescue of TXNIP protein levels upon HAase treatment. These data suggest that MDA-686 cells may be sensitive to changes in ZFP36. Alternatively, other ZFP36 family members may be important in mediating TXNIP depletion in MDA-686 cells given that these cells show upregulation of ZFP36L1 and ZFP36L2 in response to HAase whereas 293T and LiSa-2 cells do not (Figures S4B and S4C) . These ZFP36 family members may collectively target the TXNIP transcript for degradation. TXNIP mRNA is regulated at the transcriptional and post-transcriptional level, and both processes may occur in response to HAase, with their relative importance weighted differently in each cell line. Consistent with its role in programming glycolytic metabolism, MYC can suppress TXNIP transcription (Shen et al., 2015) . We detected elevated MYC levels in response to HAase in LiSa-2 and MDA-686 cells that coincided with a reduction in TXNIP ( Figure 5F ). Although the expression of ZFP36 and MYC is somewhat synchronous, their effects are likely staggered: ZFP36 acutely targets existing transcripts, whereas MYC tunes transcription in a more protracted way. The speed with which TXNIP transcript levels plummeted after HAase treatment, coupled with the rescue effect of ZFP36 knockdown, suggests a limited role for MYC in the acute regulation of TXNIP. Furthermore, knockdown of MYC in LiSa-2 cells did not affect TXNIP or ZFP36 levels at baseline or after 4 hr of HAase treatment ( Figure S4D ).
ZFP36 induction in response to HAase was transient ( Figure 5F ); therefore, MYC may be involved in determining which cells have a sustained glycolytic response to HAase and which do not. LiSa-2 cells had stably elevated MYC levels and enrichment of MYC target transcripts following HAase treatment (Figure S4E) and showed higher rates of glucose uptake and lactate production after 5 days of HAase treatment compared with 24 hr ( Figure 2C ). By contrast, induction of MYC was subtler in 293T cells, and MYC decreased at later time points, corresponding with TXNIP levels returning to baseline after 24 hr of HAase treatment ( Figure 5F ). Consistent with MYC being involved in the protracted glycolytic response to HAase, glucose uptake in 293T cells reverted toward baseline after 5 days of treatment ( Figure 2E ).
ZFP36 Induction and TXNIP Depletion Are Downstream of HAase-Stimulated RTK Activation
To determine whether HAase elicits canonical induction of ZFP36 through growth factor signaling pathways, we assessed receptor tyrosine kinase (RTK) phosphorylation. After 30 min of HAase treatment, PDGFR-b was activated in LiSa-2 cells (Figure S4F ) and EGFR in MDA-686 cells ( Figure S4G ). Ephrin A4 was also phosphorylated in LiSa-2 cells and ALK and Ephrin B3 in MEFs (Figures S4F and S4H ). To examine whether RTK signaling is upstream of ZFP36 induction, we used MDA-686 cells because they showed only EGFR activation in our array, reducing the possibility of redundant signaling events triggered by HAase. We pretreated cells with the EGFR inhibitor erlotinib at a range of concentrations before adding HAase. Erlotinib suppressed baseline ZFP36 levels and increased TXNIP levels ( Figure 5I ). When co-treated with HAase, erlotinib blocked ZFP36 induction and the subsequent decrease in TXNIP in a dose-dependent fashion. Whether the effects of HAase were MEK-dependent, however, varied among cell lines. Pretreatment with a MEK inhibitor, PD 325901, resulted in more blunted changes in ZFP36 and TXNIP upon addition of HAase in MDA-686 cells than in LiSa-2 cells and MEFs ( Figure S4I ). This disparity may result from the diversity of RTKs that can be activated by HAase and the variance in resulting signals from one cell line to another.
To assess whether ZFP36 induction and subsequent TXNIP degradation are novel features of growth factor signaling, we stimulated MDA-686 cells with epidermal growth factor (EGF) and found that it phenocopied HAase ( Figure S4J ). These results demonstrate that the metabolic effects of HAase hinge on the activation of canonical RTK signaling (see the schematic in Figure 5J ). Furthermore, they suggest a convergence of cell-extrinsic cues-growth factor signaling and matrix remodeling-on a novel mechanism by which the cell can acutely modulate its glucose consumption.
Matrix Digestion with HAase Accelerates Cell Migration in a TXNIP-and Glucose-Dependent Fashion After establishing the mechanism by which ECM remodeling with HAase affects glycolytic metabolism, we examined the functional consequences of this increased glucose metabolism and the biological contexts in which it occurs. The ECM has been described to exert both mitogenic and migratory effects on cells (Toole, 2001 ), so we hypothesized that acute metabolic regulation in response to HAase may influence cell proliferation or migration by provisioning biosynthetic intermediates and a rapid pool of ATP. (J) Proposed model depicting how ECM remodeling promotes acute upregulation of glycolysis. All experiments were biological replicates. Error bars denote SD (n = 3, unless otherwise indicated). *p < 0.05; **p < 0.01; ***p < 0.001; n.s., not significant.
To examine a potential relationship between proliferation and levels of ECM deposition, we performed immunohistochemical staining of tissue from a murine model of cutaneous squamous cell carcinoma ( Figures S5A and S5B ). The tumor-adjacent hyperplastic epidermis showed discrete regions of proliferation, indicated by positive staining for Ki-67, that anti-correlated with strong staining of the ECM constituents collagen IV (Figure S5A) and HA (probed with HABP) ( Figure S5B ). This presents two possibilities: ECM digestion is a secondary effect of proliferation-when cells respond to proliferative stimuli, they secrete matrix-digesting enzymes to accommodate tissue expansionor ECM-digesting enzymes can be secreted by neighboring cells, with changes in the surrounding matrix serving as paracrine proliferative signals.
To test whether HAase directly affects proliferation, we measured cell growth from medium density (some cell-cell contacts) to high density ( Figure S5C ). In HFF-1, LiSa-2, and MEF cells, treatment with HAase had a minimal effect on proliferation during exponential growth despite dramatically altering cell morphology ( Figure S5C ). When cell-cell contacts increased, however, HAase conferred a proliferative advantage, suggesting that HAase allows the cell to overcome contact inhibition. Although PBS-treated HFF-1 cells and MEFs formed monolayers at high density, their HAase-treated counterparts intercalated, forming lattices of cell projections ( Figure S5C ). To examine whether TXNIP is involved, we measured the growth of HAase-treated WT and Txnip KO MEFs. Despite their blunted glycolytic response to HAase, Txnip KO MEFs responded to HAase similarly to WT MEFs ( Figure S5C ). These results suggest that matrix remodeling with HAase promotes high-density cell proliferation by reducing contact inhibition but that TXNIP reduction is not involved in MEFs exposed to the abundant nutrients in cell culture medium.
To assess whether HAase increases migration and whether the glycolytic response to HAase in vitro in part supports its energetic requirements, we performed scratch assays using WT and Txnip KO MEFs. Consistent with our hypothesis, HAase-treated WT MEFs showed an increased rate of scratch closure ( Figures 6A and S5D ). However, there was no difference in migration between PBS-and HAase-treated Txnip KO MEFs, and their rates of scratch closure were the same as HAase-treated WT MEFs. These results suggest that the HAase-mediated increase in migration may depend on TXNIP downregulation and that the rate of cell migration may track with that of glycolytic metabolism.
To further assess whether TXNIP downregulation is important for the migratory response, we examined the effects of HAase on (Figures 6B and 6C) . To complement this, we overexpressed the TXNIP coding sequence, which cannot be targeted by ZFP36, in LiSa-2 cells ( Figure 6D ). Although HAase increased migration in all control cells, it had no effect in cells overexpressing TXNIP ( Figure 6E ). These data suggest that ECM remodeling with HAase serves as a migratory signal across cell types and that TXNIP downregulation via its 3 0 UTR is a central mediator of this effect. Because TXNIP reduction is necessary for optimal migration, we assessed whether glucose is limiting for migration by measuring scratch closure in LiSa-2 cells cultured with normal levels of glucose (25 mM) and in medium with glucose dropped out (1 mM) ( Figure 6F ). Although HAase increased scratch closure under both conditions, the rate of closure with HAase treatment was higher in 25 mM than in 1 mM glucose. This result was not confounded by differences in baseline migratory rates because they were the same for the 1 mM and 25 mM glucose conditions. Coupled with prior results, this suggests that basal glucose influx is limiting for migration and that the effects of TXNIP on glucose consumption likely mediate the migratory response to HAase. The glycolytic response to ECM digestion with HAase may therefore serve to rapidly generate ATP and fuel a broader migratory response to changes in the ECM.
ECM Remodeling Influences Zfp36-Txnip-Glut1
Signaling in Tissue Cultured cells are a limited system to study ECM perturbation. Although cultured cells assemble a pericellular matrix, the complexity of the ECM is lower than in most tissue. Although we demonstrated that HAase-treated tumors have increased FDG uptake ( Figures 1G and 1H) , we sought to confirm the mechanism of the glycolytic response to HAase in tissue. Given the informative gradients of cell behavior in tumor-adjacent hyperplastic epidermis ( Figures S5A and S5B) , we chemically reproduced hyperplasia of the skin using TPA and then intradermally injected it with HAase or HI HAase (Figures 7A and S6A) . HA deposits in the hyperplastic epidermis at baseline (HI HAase treatment) are largely extinguished by HAase. In this tissue, as in cell culture, depletion of HA with HAase correlates with increased Zfp36, decreased Txnip, and increased Glut1. This strengthens our cell culture findings and extends their relevance to tissue.
To examine the relationships between the ECM, Txnip, Zfp36, and glucose transporters in unmanipulated tissue, we stained neoplasms driven by KrasG12D and loss of p53 in hair follicle stem cells ( Figures 7B-7E and S6B-S6D ). This is an attractive model because high levels of proliferation and tissue disorganization produce architectural reference points. As expected, there was strong correlation between ECM constituents-HABP and collagen IV-and Txnip (Figures 7B and S6C and S6D) . Collagen IV is smaller than the HA polymer, with more discrete cellular interactions; hence, its staining pattern has clearer boundaries than HABP. Furthermore, because HABP can bind partially digested HA fragments, a faint signal is expected in areas where the ECM is being actively remodeled.
Consistent with our findings and previous reports, Txnip and Glut1 anti-correlated in these neoplasms (Figures 7C and S6B and S6D) . The regions of strongest HABP staining appeared to anti-correlate with cytoplasmic Zfp36, Ki-67, and Glut3, reinforcing the possibility of a coordinated metabolic and proliferative response to ECM digestion in nutrient-limited tissue ( Figures  7D and 7E ). Cytoplasmic Zfp36 is actively engaged in mRNA processing; some mitogenic signals that induce ZFP36 transcription also lead to its trafficking from the nucleus to the cytosol (Blackshear, 2002) . Although some baseline nuclear Zfp36 signal overlapped with Txnip and the ECM, cytoplasmic Zfp36 primarily overlapped with Ki-67 and Glut3 ( Figures 7D and 7E ). This suggests a relationship between the ECM and ZFP36-TXNIP-GLUT1 signaling that may, in part, regulate the behavior of cells in complex tissues. For example, these results raise the possibility that spatial differences in ECM deposition may contribute to the metabolic and proliferative heterogeneity of cancer cells in a tumor.
HA Digestion May Influence Glucose Metabolism in Early Mammalian Embryos
Mammalian oocytes are surrounded by the cumulus oophorus, a network of cells held together by a matrix of HA. These cells support oocyte maturation by shuttling pyruvate and other metabolites into it through membrane channels (Kidder and Mhawi, 2002) . Sperm cells have glycosylphosphatidylinisotol (GPI)-anchored HAase that disperses the cumulus, allowing fertilization of the oocyte ( Figure S7A ; Lin et al., 1994) . HA digestion coincides with the genesis of a metabolically independent zygote. Although preimplantation embryos rely predominantly on pyruvate, they both express GLUT1 and consume glucose (Purcell and Moley, 2009) . It is thought that this glucose is used for biosynthesis via glycogen synthesis and the pentose phosphate pathway (Gardner et al., 2000) . It has also been reported that glucose metabolism in murine oocytes can be regulated by Txnip (Lee et al., 2013) , suggesting that dispersal of the HA-rich cumulus may affect glucose metabolism in the early embryo.
To assess the effect of HAase-mediated cumulus dispersal on glucose metabolism in preimplantation murine embryos, we performed RNA sequencing (RNA-seq) at sequential cell divisions. Consistent with our previous findings, Zfp36 increased as Txnip decreased after dispersal of the cumulus ( Figure S7B ). Furthermore, glucose transporter transcript reads per kilo-base per million mapped reads (RPKM) values remained low at these stages of division ( Figure S7C ), suggesting that their trafficking may be a more important regulator of glucose metabolism than their transcription in the early embryo. This is consistent with a possible stimulation of glucose metabolism in early mammalian embryos by HAase-mediated regulation of ZFP36 and TXNIP.
DISCUSSION
In this study, we posit that matrix remodeling might serve-in addition to its other multivariate effects on the biology of the cell-as a node of acute cell-extrinsic metabolic regulation. That TXNIP integrates ECM signals with metabolism adds to its broad repertoire, which includes acute and protracted regulation of glucose uptake. Studies of TXNIP regulation have focused on two regulatory mechanisms: post-translational modification and transcription. Upon insulin stimulation, Akt phosphorylates TXNIP, causing it to disengage from GLUT4, untethering the transporter from clathrins and preventing its endocytosis (Waldhart et al., 2017) . Akt targets the same residue that is phosphorylated by AMPK to promote proteasomal degradation of TXNIP (Wu et al., 2013) . Although signaling can converge on TXNIP, the effects of a single signal can be multifaceted.
Transcriptional regulation of TXNIP can be dynamic or sustained. When intracellular glucose levels are elevated, the MLXIP/MLX complex binds the carbohydrate response element in the TXNIP promoter, upregulating transcription as part of a negative feedback loop (Stoltzman et al., 2008) . Conversely, MLXIP/MLX activity is repressed when cells enter G 1 and require biosynthetic glucose metabolites for anabolism (Elgort et al., 2010) . TXNIP is also stably downregulated, most notably by MYC, which represses its transcription as part of a broad glycolytic program (Shen et al., 2015) .
Although TXNIP can be modulated by a microRNA during programmed cell death (Lerner et al., 2012) , regulation of TXNIP transcript stability has not been described in the context of metabolism. Here we provide evidence for acute regulation of TXNIP by the mRNA decay factor ZFP36. Targeting TXNIP transcript stability gives the cell a nimble way to regulate its glycolytic rate in response to external stimuli and to coordinate it with punctuated cellular behaviors like migration. ZFP36 regulation of glucose metabolism has not been described previously but is likely not limited to ECM remodeling. Because ZFP36 can be induced by both growth factors and cytokines, it may be an additional dimension of their effect on glycolytic metabolism. Like ECM signals, growth factors and cytokines often elicit acute cellular responses, and ZFP36-mediated destabilization of TXNIP mRNA may provide a rapid way to upregulate glycolysis without augmenting or reprogramming baseline glycolytic machinery; this is a rapid and reversible way to toggle the glycolytic valve.
This mechanistic link between ECM remodeling and glucose metabolism might further explain the heterogeneity of cells within tissues. Changes in the ECM could elicit spatially and temporally circumscribed cellular responses. Hanahan and Weinberg (2011) have lamented the difficulty of assessing proliferative regulation in normal tissue because of the heterogeneous nature of paracrine signaling-as opposed to cancer cells, they argue, which are easier to understand given the constitutive activity of these signals. But tumors, too, show spatial heterogeneity not only in mutational status but also in metabolism and proliferation (Hensley et al., 2016; Meacham and Morrison, 2013) . Our data suggest the possibility that, within such asynchronous tissue, local modulation of the matrix may be a way to elicit acute coordination of these interdependent processes.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
DECLARATION OF INTERESTS
The authors declare no competing interests. 
CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Heather Christofk (hchristofk@mednet.ucla.edu)
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell culture Cells were maintained using standard tissue culture procedures in a humidified incubator at 37 C with 5% CO 2 and atmospheric oxygen. 293T (human, female), 3T3-L1 (mouse, male), A431 (human, female), HCT116 WT and p53À/À (human, male), HeLa (human, female), HFF-1 (human, male), HPSC (human, female), Hs578T (human, female), LPS2 (human, male), LPS3 (human, male), MDA-686 (human, male), MDA-MB-231 (human, female), MDA-MB-453 (human, female), WT and Txnip knockout MEFs (mouse, sex unspecified), MIA-PaCa-2 (human, male), PANC-1 (human, male), SNL76/7 (mouse, mixed sex), and U-87 (human, male) cells were cultured in DMEM supplemented with 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin (pen/strep); A549 (human, male), NCI-H1437 (human, male), NCI-H157 (human, male), NCI-H1792 (human, male), NCI-H358 (human, male), NCI-H441 (human, male), NCI-H460 (human, male), NCI-H520 (human, male), and NCI-H661 (human, male) cells in RPMI 1640 supplemented with 10% FBS and 1% pen/strep; LPS3 (human, male) cells in DMEM/F12 supplemented with 10% FBS and 1% pen/strep; LiSa-2 (human, male) cells in DMEM/F12 supplemented with 10% bovine serum and 1% pen/strep; MCF-10A (human, female) and MCF12A (human female) cells in DMEM/F12 supplemented with 5% horse serum, 10mg/mL insulin, 10mg/mL cholera toxin (Sigma), 500ng/mL hydrocortisone, and 20ng/mL EGF; and SUM149PT (human, female) and SUM159PT (human, female) cells in Ham's F12 supplemented with 5% FBS, 1% pen/strep, 5mg/mL insulin, 1mg/mL hydrocortisone, and 10ng/mL EGF. Base media, sera, mitogens, and pen/strep were all obtained from GIBCO. NBHE (human, male) cells were grown in proprietary serum-free growth media without antibiotics (Lonza).
LiSa-2 liposarcoma cells were generated and provided by Dr. Peter Mö ller (University of Ulm), and are a compelling model to study glycolytic activation as they have the lowest baseline glucose uptake rate of any cell line we have tested. All experiments reported here have been performed with these cells unless otherwise indicated.
Additional cell lines tested were purchased or procured from a variety of sources. Liposarcoma cell lines LPS2 and LPS3 were established in our lab from patient-derived xenografts in collaboration with Dr. Hong Wu (University of California, Los Angeles). (Hwang et al., 2008) Institute, Preclinical Imaging Technology Center. When tumors were $200 mm 3 mice were injected via lateral tail vein with $70-80 mCi 18F-FDG, underwent 60min uptake under 1.5% isoflurane anesthesia, followed by microPET and microCT (G8 PET/CT, PerkinElmer) imaging. The following day, each mouse received intratumoral injection (tumor in one flank) with either active HAase (50mL, 400mg/mL) or heat-inactivated HAase (tumor in the other flank) and 6h later mice underwent second 18F-FDG imaging following the same procedure as above. Quantification of 18F-FDG uptake was done using AMIDE software (Loening and Gambhir, 2003) by drawing region of interest (ROI) over tumor and plotting mean uptake values as percent injected dose per gram (% ID/g). Genetic model of tumorigenesis Mice were acquired from The Jackson Laboratory (K15CrePR) and from the National Cancer Institute Mouse Models of Human Cancers Consortium repository (LSL-KrasG12D and p53ff) and K15CrePR mice express mifepristone-inducible cre recombinase driven by the promoter of Krt15, a member of the keratin family whose expression is pronounced in epithelial stem cells located in the bulge of the hair follicle. K15CrePR; KrasG12D; p53ff animals were treated with intraperitoneal injections of mifepristone (10mg/mL dissolved in sunflower seed oil; 2mg per day) for 3-5d before the start of the second adult hair cycle (10 weeks postnatal). Papillomas followed by bona fide squamous cell carcinomas developed in treated animals 6-10 weeks after anagen. Tissues were used for immunohistochemistry. Chemical model of hyperplasia C57BL/6J mice (6 week old males) were acquired from The Jackson Laboratory. Mice were shaven and treated topically with 12-Otetradecanoylphorbol-13-acetate (TPA) twice over the course of a week to induce hyperplasia of the epidermis. TPA was dissolved in 100% ethanol to 5nM; 100 mL was used per application. Each mouse then received an intradermal injection of HAase (50mL, 400mg/mL) into one dorsal flank and HI HAase into the opposite flank. Skin was harvested 6h later.
METHOD DETAILS
Enzyme & drug treatments Hyaluronidase (HAase) from bovine testes (Sigma) was reconstituted in PBS at 40mg/mL and treated at 1:100 for a final concentration of 400 mg/mL. This concentration of HAase was determined based on the dose-response relationship established in LiSa-2 cells ( Figure S1A ). This concentration is above the minimum dose needed to achieve the maximum glycolytic response in these cells, but was selected to buffer against variations in enzymatic activity between lots of HAase and to account for the possibility of decreased sensitivity in other cells. PBS was used as the vehicle control, paired with the longest HAase treatment when multiple time points were assayed. For multi-day time points, media and enzyme were refreshed every other day as appropriate. Heatinactivated (HI) HAase was prepared by boiling for 15min at 95 C; the resulting preparation was then quickly centrifuged to remove protein aggregates.
The following additional hyaluronidases were used to confirm on-target effects of the primary enzyme preparation: hyaluronidase isolated from Streptomyces hyaluronlyticus (EMD Millipore) and recombinant human PH-20 (Abcam). HA was also depleted using 4-methylumbelliferone (Sigma), an inhibitor of HA synthesis. For 4-MU experiments, cells were resuspended and plated in media containing the compound (or solvent, DMSO) so that cells were unable to assemble a pericellular matrix of HA. Metabolic measurements and imaging were performed such that the final readout was collected 48h and 24h after plating, respectively. Apigenin (Tocris), A-769662 (Tocris), erlotinib (Cayman), PD 325901 (Sigma), and SP600125 (Tocris) were dissolved in DMSO. HAase and apigenin (or DMSO) were co-incubated in media for 1h before being added to cells. Erlotinib, PD 325901, and SP600125 were added to cells 1h prior to addition of HAase. Before interrogation of signaling events, cells were serum starved overnight as indicated.
Metabolic rate measurements
Media glucose, glutamine, and lactate concentrations were measured using a Bioprofile Basic Analyzer (Nova Biomedical). Cells were seeded in 6-well plates at densities such that measurements would be made on subconfluent cells. Media was refreshed 24h after seeding cells; media was also added to empty wells as blank controls. After 24h incubation, 1mL media was removed from each sample and the blanks, and metabolite levels were assessed. Cell number was then determined using a Z1 Particle Counter (Beckman Coulter). Rates were calculated by dividing the difference in metabolite levels between samples and blanks by both the measurement interval (24h) and cell number. Please note we are cautious about making quantitative inferences regarding the absolute magnitude of the fold changes in glucose uptake and lactate production across cell lines and across experiments. Though these are informative metrics for comparisons across conditions, cell lines with very low levels of baseline glycolytic activity (like LiSa-2 cells) can appear to respond with dramatically different magnitude between experiments due to small absolute differences in the denominator of the fold-change calculations (which is to say, the rate in the control condition). These differences are both technical (insensitivity of the instrument in measurement of small changes) and biological (e.g., changes in baseline rate due to passage number, serum lot, sensitivity to solvents such as DMSO). In this report, we focus on internal comparisons of magnitude across conditions within individual experiments and cell lines.
Extracellular acidification rate (ECAR) measurement
Real-time measurements of extracellular pH were completed on a Seahorse XF96 Extracellular Flux Analyzer. LiSa-2 cells were seeded in a XF96 microplate at a density of 5,000 cells/well 48h prior to experiment and maintained under standard tissue culture conditions with treatments of HAase as indicated. Cells were then washed twice with assay media (XF Base Medium supplemented with 17mM glucose and 2.5mM glutamine, pH 7.4) and brought to a final volume of 175mL per well. The microplate was placed in a 37 C incubator without CO 2 for 30min prior to loading the plate into the instrument. The extracellular acidification rate was measured over the course of 75min; midpoint measurements are presented.
Immunoblotting Whole-cell lysates were prepared with RIPA buffer supplemented with phosphatase inhibitors (20mM sodium fluoride and 1mM sodium orthovanadate) and protease inhibitors (aprotinin, leupeptin, pepstatin -all at 4 mg/mL). A PM Protein Extraction Kit (Abcam) was used for fractionation of the PM and the cytosol according to manufacturer's protocol, but with additional centrifugation steps to ensure maximal phase separation. Because we observed that boiling caused aggregation of membrane proteins and poor resolution by SDS/PAGE, lysates were denatured at room temperature for 30min following the addition of sample buffer as this prevented the aggregation of membrane proteins.
The following primary antibodies were used: p-ACC Ser79 (Cell Signaling 3661, 1:1,000), b-actin (Cell Signaling 4970, 1:1,000), ALDOA (Cell Signaling 3188, 1:1,000), CD44 (Cell Signaling 3578, 1:1,000), p-c-Jun Ser63 (Cell Signaling 2361, 1:1,000), EGFR (Cell Signaling 4267, 1:1,000), p-EGFR Tyr1068 (Cell Signaling 3777, 1:1,000), ELK-1 (Cell Signaling 9182, 1:1,000), p-ELK-1 Ser383 (Cell Signaling 9181, 1:1,000), ENO1 (Cell Signaling 3810, 1:1,000), ERK1/2 (Cell Signaling 4695, 1:1,000), p-ERK1/2 Thr202/Tyr204 (Cell Signaling 4370, 1:1,000), GAPDH (Invitrogen AM4300, 1:1,000), GLUT1 (Abcam ab115730, 1:1,000 for wholecell lysates, 1:5,000 for PM fractions), GLUT3 (Abcam ab191071, 1:1,000), HK2 (Cell Signaling 2867, 1:1,000), HMMR/CD168 (Abcam ab108339, 1:1,000), ITCH (Cell Signaling 12117, 1:1,000), p-ITCH Thr222 (EMD Millipore AB10050, 1:500), LDHA (Cell Signaling 3582, 1:1,000), LDHB (Abcam ab75167, 1:500), MCT1 (Abcam ab85021, 1:1,000), MYC (Cell Signaling 5605, 1:1,000), Na,K-ATPase (Cell Signaling 3010, 1:1,000), a-tubulin (Sigma T6074, 1:10,000), TXNIP (Cell Signaling 14715, 1:1000), ZFP36/tristetraprolin (Cell Signaling 71632, 1:1000). Where shown, bands were quantified using ImageJ (NIH).
Screening for activation (phosphorylation) of receptor tyrosine kinases was performed using the Proteome Profiler Human Phospho-RTK Array Kit (R&D Systems) per manufacturer's protocol. 100-300 mg of cell lysate was used from cells treated with PBS or HAase for 30min.
Fluorescence microscopy Cultured cells
Cells were seeded at subconfluent densities on acid-washed coverslips. After indicated treatment, cells were fixed in 4% paraformaldehyde for 20min. For GLUT1 staining, cells were permeabilized for 5min in 0.1% Triton X-100 in PBS then blocked in 10% goat serum in PBS for 30min. For HABP staining, cell membranes remained intact and were blocked using an avidin/biotin blocking kit (Vector Laboratories). Cells were probed with a GLUT1 antibody (Abcam ab115730, 1:100) or biotinylated HA binding protein (HABP, EMD Millipore, 1:100) overnight at 4 C, then incubated with Alexa Fluor 488-conjugated goat anti-rabbit IgG and Alexa Fluor 555-conjugated streptavidin (both ThermoFisher), respectively, at a dilution of 1:500 in blocking buffer for 1h at room temperature. Coverslips were then mounted with ProLong Gold Antifade with DAPI (Invitrogen) and cured overnight before sealing. GLUT1 images were then collected on a Nikon Eclipse 90i Microscope and HABP on a Zeiss Axio Imager.M1 Microscope. Tissue sections Isolated tissues were embedded fresh in OCT compound (Fisher Scientific). The tissue was sectioned with a Leica 3200 Cryostat, and fixed for 5-10min in 4% paraformaldehyde. All sections were blocked in staining buffer containing appropriate control IgG.
The following steps were then performed using the same protocol as cultured cells. Sections were probed with the following antibodies: Glut1 (Abcam ab115730; 1:250), Txnip (Abcam ab188865; 1:100), and ZFP36/tristetraprolin (LSBio LS-B1572, 1:200). Sections were also probed using HABP (EMD Millipore, 1:50). Antibodies and HABP were then incubated, respectively, with Alexa Fluor 488-conjugated goat anti-rabbit IgG and Alexa Fluor 488-conjugated streptavidin (both ThermoFisher) at a concentration of 1:500, and mounted using the same Antifade reagent. Images were collected on a Zeiss Axio Imager.A1 Microscope.
Intracellular metabolite extraction and mass spectrometry-based metabolomics Cells were seeded in 6-well plates such that they were at $75% confluency at the time of metabolite extraction. Media containing 10mM U-13 C 6 -glucose (Cambridge Isotope Labs) and PBS or HAase was added to cells at indicated time points before extraction. Cells were washed with 150mM ammonium acetate and scraped into 800 mL chilled 50% methanol. 10nM norvaline was added to the suspension as an internal standard, followed by 400 mL chloroform. After repeated vortexing, the aqueous layer containing metabolites was transferred to a glass vial and dried under vacuum. Metabolites were resuspended in 100 mL 70% acetonitrile (ACN) and 5 mL of this solution used for the mass spectrometer-based analysis. The analysis was performed on a Q Exactive (Thermo Scientific) in polarity-switching mode with positive voltage 3.0 kV and negative voltage 2.25 kV. The mass spectrometer was coupled to an UltiMate 3000 RSLC (Thermo Scientific) UHPLC system. Mobile phase A was 5mM NH4AcO, pH 9.9, B) was ACN, and the separation achieved on a Luna 3mm NH2 100A (150 3 2.0mm) (Phenomenex) column. The flow was 300 mL/min, and the gradient ran from 15% A to 95% A in 18min, followed by an isocratic step for 9min and re-equilibration for 7min. Metabolites were detected and quantified as area under the curve (AUC) based on retention time and accurate mass (%3ppm) using the TraceFinder 3.1 (Thermo Scientific) software. Relative amounts of metabolites between conditions, as well as percentage of labeling, were calculated and corrected for naturally occurring 13 C abundance.
Gene knockdown, knockout & overexpression Knockdown Stable knockdown of gene expression was achieved using targeted shRNA sequences in the pLKO.1-puro backbone (Sigma) and inducible knockdown in the pLKO-Tet-On backbone (Wiederschain et al., 2009) . A nonspecific scramble sequence was used as a control in both cases. Knockdown was induced with doxycycline at 500ng/mL at time points indicated. shRNA sequences can be found in Table S1 . Overexpression Constitutive expression of TXNIP was achieved using a CMV-driven N-terminal 3xFLAG-tagged TXNIP expression vector with a blasticidin-resistance cassette (pLV[Exp]-Bsd-CMV > 3xFLAG/hTXNIP[NM_006472.4]) (Cyagen Biosciences). Inducible expression of TXNIP was achieved using the pLVX-TetOne-Puro backbone (Clontech); cells were treated with doxycycline at 500ng/mL at time points indicated. For inducible expression experiments, an empty vector backbone (EV) was used as a control.
Viral transduction
For both knockdown and overexpression, lentiviral particles were produced by co-transfecting 293T cells with construct of interest along with the gag/pol, rev, and vsvg packaging plasmids using PolyFect Transfection Reagent (QIAGEN). Virus was collected 48h later, filtered through 0.45 mm pores, and added to subconfluent target cells with 4 mg/mL polybrene (Santa Cruz) overnight. Transduced cells were allowed to recover in regular growth media for 24h and then were selected with the appropriate resistance marker: 1 mg/mL puromycin or 10 mg/mL blasticidin (both Invivogen). CRISPR knockout MDA-MB-231 cells were transfected using Lipofectamine 3000 (ThermoFisher) in a 12-well plate with a pool of plasmids encoding GFP, Cas9, and 1 of 3 TXNIP-specific gRNAs (Santa Cruz) in order to generate indels. Cells were trypsinized into a single cell suspension 48h post transfection, sorted by GFP expression using a FACSAria cell sorter (BD), and seeded in 96-well plates at a density of 1 cell per well. After $3 wks, wells with colonies were expanded and each clonal line was analyzed for TXNIP mRNA by qRT-PCR and protein by western blot.
TXNIP UTR reporter analysis
The human TXNIP 3 0 UTR (1.4kb) was amplified from genomic DNA isolated from HeLa cells using KAPA HiFi polymerase (Kapa). The human TXNIP UTR sequence was cloned upstream of a luciferase gene (luc2 gene, Promega) in a pcDNA3.1(+) backbone. Human ZFP36 cDNA (GE Dharmacon) was subcloned into an M4 expression vector backbone, where it is driven by a CMV promoter. The luciferase reporter construct (100ng) was transfected alongside transfection control plasmid (pCMX b-gal, 50ng) (Tarling et al., 2017) and either increasing amounts of the M4-ZFP36 expression plasmid or pcDNA3.1(+) (up to 50ng) per well of a 48-well plate. Transfection was carried out using FuGENE HD (Promega) according to manufacturer's instructions into HEK293 cells plated onto 48-well dishes (n = 6 wells/condition). After overnight incubation with the transfection mixture, media was replaced for further 24h before cells were harvested. Cells were then treated for 0.5-6h with HAase-containing media before being harvested. Cell lysates were assayed for luciferase activity using the Luciferase Assay System (Promega) and luciferase activity was normalized to b-gal activity to correct for differences in transfection efficiency. Data are expressed as fold change relative to TXNIP UTR luciferase activity with no experimental treatments.
Quantitative Real-Time PCR Total RNA was isolated using the QIAGEN RNeasy Kit and 700ng was used as template for each cDNA synthesis reaction with the iScript Kit (Bio-Rad). Each reaction was then diluted to a total volume of 100 mL with ultrapure water. For qPCR, 2 mL of the diluted cDNA was combined with 0.5 mM primers and KAPA SYBR FAST master mix (Kapa Biosystems) and amplified on a LightCycler 480 (Roche). Relative quantification was then performed using the DDC t method with RPLP0 as the reference gene. Primer sequences can be found in Table S2 .
Cell proliferation & viability
Cells were seeded in 6-well plates such that triplicate measurements could be made at each indicated time point. Media was refreshed every other day as appropriate. Cells were trypsinized and counted using a Z1 Particle Counter (Beckman Coulter). Phase-contrast images were captured at indicated time points using a Zeiss Axiovert 40 CFL Microscope. Cell viability was determined by trypan blue exclusion using a Vi-CELL XR (Beckman Coulter).
Scratch assay
Cells were grown to confluency in 6-well plates and mitotically inactivated with mitomycin C (10 mg/mL for MEFs; 5 mg/mL for all others) for 2h to rule out the possibility that differences in proliferation could confound the results. Given rapid rate of scratch closure, MEFs (WT and Txnip KO) and MDA-MB-231 cells (WT and TXNIP KO) were subsequently pretreated for 12h with PBS or HAase before a P20 tip was used to make two intersecting scratches in the monolayer of each triplicate well. Given slower absolute rate of closure, LiSa-2 cells (parental, EV & tet-TXNIP) were treated with PBS or HAase in tandem with monolayer disruption. For the TXNIP overexpression experiment, LiSa-2 cells transduced tet-TXNIP or EV control were additionally pretreated with doxycycline (500ng/mL) or vehicle 12h prior to scratch. For the glucose dropout experiment, parental LiSa-2 cells were switched to media with indicated concentration of glucose at the time of treatment. In all cells, numerous washes with media were performed after scratch to remove cell debris. Phase-contrast images were captured for each well using a Zeiss Axiovert 40 CFL Microscope at indicated times following disruption of the monolayer. Absolute area closed at each time point was determined by manual tracing of wound edges and subsequent area quantification in ImageJ.
Immunohistochemistry
Isolated tissues were fixed overnight in 4% formalin and embedded in paraffin. Sections were then de-paraffinized, prepared for histology, and blocked in staining buffer containing appropriate IgG control. Immunohistochemistry was performed with citrate or Tris buffer antigen retrieval with the following antibodies: collagen IV (Abcam ab6586, 1:500), Glut1 (Abcam ab115730; 1:250), Glut3 (Abcam ab15311; 1:50), K14 (Abcam ab181595, 1:1000), Ki-67 (Abcam ab16667; 1:50), Txnip (Abcam ab188865; 1:100), and ZFP36/tristetraprolin (LSBio LS-B1572, 1:200). The EnVision+ HRP Peroxidase System and AEC Substrate Chromogen (both Dako) were used for detection. Biotinylated HA binding protein (EMD Millipore, 1:50) was also used as a probe, and detected with the VECTASTAIN Elite ABC-HRP Kit (Vector Laboratories). Images were collected on a CX43 Biological Microscope (Olympus).
RNA-Seq library construction & analysis
Total RNA was isolated from murine embryos derived as previously described (Nagaraj et al., 2017) using the Quick-RNA Microprep Kit (Zymo) according to manufacturer's protocol. Total RNA fraction was processed and libraries were generated using the Ovation Ultralow Library System V2 (NuGEN). The resulting purified cDNA library was sequenced on the Illumina HiSeq 2000. 50bp single-end RNA-seq reads were obtained, and sequence files were generated in FASTQ format. The quality score of RNA-seq reads was obtained using FastQC. Reads were then aligned to the UCSC mm10 Mus musculus reference sequence from Illumina iGenome using TopHat v2.0. 10 (Trapnell et al., 2009) . Transcript assembly and estimation of abundance were performed with Cufflinks 2.1.1. Differential expression of genes across conditions was calculated with Cuffdiff 2.1.1 (Trapnell et al., 2010) .
Gene Set Enrichment Analysis (GSEA) Total RNA was isolated with the QIAGEN RNeasy Kit and used by the UCLA Clinical Microarray Core to perform whole-genome expression analysis with the GeneChip Human Genome U133 Plus 2.0 array (Affymetrix). Gene set enrichment analysis (Subramanian et al., 2005) was performed using annotations in the Molecular Signatures Database (MSigDB) C2 collection.
Enzymatic activity assays
The Hexokinase Colorimetric Assay Kit and Phosphofructokinase Activity Colorimetric Assay Kit (both BioVision) were used per manufacturer's protocol with 5 mg and 0.1 mg cell lysate, respectively. Readout absorbance at 450nm is proportional to NADH production. Lactate dehydrogenase activity was measured by NADH fluorescence (absorption: 340nm, emission: 465nm) when 2 mg lysate was combined with 100 mL kinetic buffer (50mM Tris pH 7.5, 100mM KCl, 5mM MgCl 2 , 1mM pyruvate). In all cases, enzyme activity was calibrated against an NADH standard curve.
QUANTIFICATION AND STATISTICAL ANALYSIS
All experiments were performed in biological triplicate unless otherwise indicated. The ''N'' for each experiment can be found in the figure legends and represents independently generated samples for in vitro experiments, cell populations / wells for live cell experiments, and mice for all in vivo experiments. Bar graphs present the mean ± SD; p values were generated for these, and for heatmaps of metabolite pool sizes, by two-tailed Student's t test. HMMR expression scatterplots were analyzed by linear regression. Throughout the figures, asterisks indicate the significance of the p value: *p < 0.05; **p < 0.01; ***p < 0.001. A significant result was defined as p < 0.05. Date were analyzed and visualized using GraphPad Prism.
DATA AND SOFTWARE AVAILABILITY
Microarray data have been deposited in NCBI's Gene Expression Omnibus (GEO: GSE105034). 
